222 related articles for article (PubMed ID: 14736249)
1. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
Buck SB; Huff JK; Himes RH; Georg GI
J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
[TBL] [Abstract][Full Text] [Related]
3. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
[TBL] [Abstract][Full Text] [Related]
4. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxicity studies of new cryptophycin analogues.
Liu WL; Zhang JC; Jiang FQ; Fu L
Arch Pharm (Weinheim); 2009 Oct; 342(10):577-83. PubMed ID: 19714674
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
[TBL] [Abstract][Full Text] [Related]
7. Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24.
Vidya R; Eggen M; Georg GI; Himes RH
Bioorg Med Chem Lett; 2003 Feb; 13(4):757-60. PubMed ID: 12639575
[TBL] [Abstract][Full Text] [Related]
8. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
Georg GI; Ali SM; Stella VJ; Waugh WN; Himes RH
Bioorg Med Chem Lett; 1998 Aug; 8(15):1959-62. PubMed ID: 9873466
[TBL] [Abstract][Full Text] [Related]
9. Benzoylphenylurea sulfur analogues with potent antitumor activity.
Hallur G; Jimeno A; Dalrymple S; Zhu T; Jung MK; Hidalgo M; Isaacs JT; Sukumar S; Hamel E; Khan SR
J Med Chem; 2006 Apr; 49(7):2357-60. PubMed ID: 16570932
[TBL] [Abstract][Full Text] [Related]
10. Antitumor agents. 174. 2',3',4',5,6,7-Substituted 2-phenyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.
Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1997 Jul; 40(14):2266-75. PubMed ID: 9216846
[TBL] [Abstract][Full Text] [Related]
11. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, conformational analysis, and cytotoxicity of new analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Copper JE; Smith CD; Gomez-Paloma L; Riccio R
J Nat Prod; 2004 Aug; 67(8):1325-31. PubMed ID: 15332850
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 15,20-triamide analogue with polar substituent on the phenyl ring of arenastatin A, an extremely potent cytotoxic spongean depsipeptide.
Kotoku N; Kato T; Narumi F; Ohtani E; Kamada S; Aoki S; Okada N; Nakagawa S; Kobayashi M
Bioorg Med Chem; 2006 Nov; 14(22):7446-57. PubMed ID: 16877000
[TBL] [Abstract][Full Text] [Related]
17. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
Smith CD; Zhang X; Mooberry SL; Patterson GM; Moore RE
Cancer Res; 1994 Jul; 54(14):3779-84. PubMed ID: 7913408
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies of targeting ligands against breast cancer cells.
Yao N; Xiao W; Meza L; Tseng H; Chuck M; Lam KS
J Med Chem; 2009 Nov; 52(21):6744-51. PubMed ID: 19835381
[TBL] [Abstract][Full Text] [Related]
19. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis of the cyclodepsipeptide apratoxin A and its analogues and assessment of their biological activities.
Ma D; Zou B; Cai G; Hu X; Liu JO
Chemistry; 2006 Oct; 12(29):7615-26. PubMed ID: 16832801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
